A clinical trial testing the oral therapy tebapivat for sickle cell disease is fully enrolled, with early results expected later this year.

Wilson explains how new experiences help him gather evidence that things can go well, even with sickle cell disease.

Differences in red blood cell stiffness may help to explain variations in the severity of sickle cell disease (SCD), ...

The FDA has awarded breakthrough device designation to Hemex Health’s rapid diagnostic test for sickle cell disease and beta ...

Being a doctor with sickle cell disease helps columnist Oluwatosin Adesoye relate to patients, but it also presents ...

Screening children for certain clotting proteins may help clinicians in resource-poor settings identify serious complications ...

Pain is part of sickle cell disease crises, but columnist Oluwatosin Adesoye says it shouldn't keep you from pursuing goals.

Chronic pain among adolescents and young adults with sickle cell disease (SCD) is associated with more functional disability — meaning patients are less able to independently perform daily activities ...

Researchers from the University of Illinois Chicago (UIC) have received $3.78 million in federal funding to evaluate whether a diabetes medication can slow kidney damage in people with sickle cell ...

Note: This column describes the author’s own experiences with hydroxyurea and thoughts about other treatment options. Not everyone will have the same response to treatment. Consult your doctor before ...

Memantine, an oral medication that’s been used for decades to help treat Alzheimer’s disease, is generally tolerated well by people with sickle cell disease (SCD) and may help prevent painful disease ...

I recently had the first-ever MRI scan of my brain, not something I ever expected. I found this both surprising and thought-provoking. Over the years, I’ve heard other people with sickle cell share ...